cardiomyopathy
Showing 1 - 25 of 124
Uncommon Presentations and/or Uncommon Diseases Associated With
Recruiting
- Cardiomyopathy
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass
Active, not recruiting
- Cardiomyopathy
-
Saint Louis, MissouriWashington University School of Medicine
Jan 30, 2023
SNPs in p53 and p53 Response Elements on Inflammatory Response
Completed
- HIV-1 Seropositive
- +3 more
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 21, 2023
Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation Trial in Los Angeles, Baltimore, Nashville (Cardiac
Recruiting
- Sudden Cardiac Death
- +3 more
- Cardiac Sympathetic Denervation (CSD)
- Routine Care
-
Los Angeles, California
- +2 more
Jan 9, 2023
Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity Trial in Rochester (Semaglutide, Placebo,
Recruiting
- Cardiomyopathy
- +2 more
- Semaglutide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 3, 2023
Characterization of Arrhythmia-induced Cardiomyopathy
Recruiting
- Cardiomyopathy
- Arrhythmia-induced Cardiomyopathy (AiCM)
- Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Cardiology
Jan 2, 2023
Cardiomyopathy, Cardiovascular Diseases, CHF Trial in Atlanta (Undersizing Mitral Annuloplasty, Papillary Muscle Approximation)
Recruiting
- Cardiomyopathy
- +6 more
- Undersizing Mitral Annuloplasty
- Papillary Muscle Approximation
-
Atlanta, Georgia
- +2 more
Dec 19, 2022
Pediatric MYBPC3 Mutation-associated Cardiomyopathy
Recruiting
- Cardiomyopathy
-
Little Rock, Arkansas
- +17 more
Nov 23, 2022
Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)
Recruiting
- Amyloidosis, Primary
- Cardiomyopathy
- F-18 florbetapir/C-11 acetate PET
- +2 more
-
Boston, MassachusettsBrigham and Womens' Hospital
Oct 23, 2022
Cardiomyopathy, Pregnancy Related Trial in Nigeria (Artificial Intelligence enabled electrocardiogram (AI-ECG))
Recruiting
- Cardiomyopathy
- Pregnancy Related
- Artificial Intelligence enabled electrocardiogram (AI-ECG)
-
Dutse, Jigawa, Nigeria
- +5 more
Aug 16, 2022
Cardiomyopathy, Heart Failure, Coronary Artery Disease Trial in Sydney, Berlin, London
Active, not recruiting
- Cardiomyopathy
- +5 more
-
Sydney, New South Wales, Australia
- +3 more
Jun 21, 2022
Patients' Long-Term Survival of Obstructive Hypertrophic
Completed
- Cardiomyopathy
- Obstructive Hypertrophic Cardiomyopathy
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
May 27, 2022
Contractile Reserve in Dyssynchrony: A Novel Principle to
Active, not recruiting
- Heart Failure
- Cardiomyopathy
- Diagnostic interventions; PET, MRI, cardiac ultrasound.
-
Leuven, Belgium
- +1 more
May 24, 2022
Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell
Completed
- Cardiomyopathy
- Heart Failure
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 11, 2022
Aortic Coarctation, Cardiomyopathy, Atrial Septal Defect Trial in Washington (MRI guided cardiac catheterization, Magnetic
Active, not recruiting
- Aortic Coarctation
- +5 more
- MRI guided cardiac catheterization
- Magnetic resonance imaging
-
Washington, District of ColumbiaChildren's National Health System
Mar 28, 2022
Cardiomyopathy Trial in Baltimore (Metoprolol)
Terminated
- Cardiomyopathy
-
Baltimore, MarylandUniversity of Maryland
Feb 23, 2022
Cardiomyopathy, Heart Failure, Left Bundle Branch Block Trial in Portland (Adaptive cardiac resynchronization therapy,
Completed
- Cardiomyopathy
- +2 more
- Adaptive cardiac resynchronization therapy
- Conventional Cardiac Resynchronization Therapy
-
Portland, OregonOregon Health and Science University
Jan 11, 2022
Cardiomyopathy, Coronary Artery Disease, CHF Trial in United States (Implantable Cardioverter Defibrillator, Optimal Medical
Terminated
- Cardiomyopathy
- +3 more
- Implantable Cardioverter Defibrillator
- Optimal Medical Therapy
-
Washington, District of Columbia
- +4 more
Dec 21, 2021
Budapest Upgrade CRT Study (Version 009-4.1)
Active, not recruiting
- Cardiomyopathy
- CRT-D
-
Hannover, Germany
- +16 more
Jan 6, 2022
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Completed
- Amyloidosis
- +4 more
-
Cleveland, OhioLutheran Hospital
Dec 21, 2021
Ventricular Tachycardia, Cardiomyopathy, Premature Ventricular Contractions Trial in Saint Louis (stereotactic body radiotherapy
Active, not recruiting
- Ventricular Tachycardia
- +2 more
- stereotactic body radiotherapy (SBRT)
-
Saint Louis, MissouriWashington University School of Medicine
Dec 1, 2021
Duchenne Muscular Dystrophy, Cardiomyopathy, Heart Failure Trial in Paris (Nebivolol, Placebo)
Completed
- Duchenne Muscular Dystrophy
- +2 more
- Nebivolol
- Placebo
-
Paris, FranceArmand Trousseau Hospital
Sep 27, 2021
Cardiomyopathy Trial in London (Eplerenone, Placebo)
Completed
- Cardiomyopathy
- Eplerenone
- Placebo
-
London, United KingdomRoyal Brompton & Harefield NHS Trust
Sep 14, 2021
Cardiomyopathy Trial in Damascus (mono nuclear cells injection, Digoxin+furosemide+captopril)
Recruiting
- Cardiomyopathy
- mono nuclear cells injection
- Digoxin+furosemide+captopril
-
Damascus, Syrian Arab RepublicChildren'S Hospital
Aug 17, 2021
Cardiomyopathy, Renal Impairment Trial in Rochester (Tadalafil, Placebo)
Completed
- Cardiomyopathy
- Renal Impairment
- Tadalafil
- Placebo
-
Rochester, MinnesotaMayo Clinic
Jun 4, 2021